[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3887 Reported in House (RH)]
<DOC>
Union Calendar No. 629
118th CONGRESS
2d Session
H. R. 3887
[Report No. 118-758]
To amend title III of the Public Health Service Act to reauthorize the
program of payments to children's hospitals that operate graduate
medical education programs, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 7, 2023
Mr. Crenshaw introduced the following bill; which was referred to the
Committee on Energy and Commerce
November 20, 2024
Additional sponsors: Mr. Johnson of Ohio, Mrs. Miller-Meeks, Mrs.
Harshbarger, Mr. Pfluger, Mr. Babin, Mr. Self, Mrs. Miller of West
Virginia, Ms. Tenney, Mr. Santos, Mr. Van Drew, Mr. Grothman, Mr. Scott
Franklin of Florida, Mr. Gaetz, Mr. Nehls, Mrs. Cammack, Mr. Stauber,
Mr. Williams of Texas, Mr. Arrington, Mr. Mann, Mr. Norman, Mr. Posey,
Mr. Steube, Mr. Ellzey, Mr. Carter of Georgia, Mr. Green of Tennessee,
Mr. Jackson of Texas, Mr. Mooney, Mr. Duncan, Mrs. Miller of Illinois,
Mr. Moran, Mr. Finstad, and Mr. Rouzer
November 20, 2024
Reported with an amendment, committed to the Committee of the Whole
House on the State of the Union, and ordered to be printed
[Strike out all after the enacting clause and insert the part printed
in italic]
[For text of introduced bill, see copy of bill as introduced on June 7,
2023]
_______________________________________________________________________
A BILL
To amend title III of the Public Health Service Act to reauthorize the
program of payments to children's hospitals that operate graduate
medical education programs, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Children's Hospital GME Support
Reauthorization Act of 2023''.
SEC. 2. PROGRAM OF PAYMENTS TO CHILDREN'S HOSPITALS THAT OPERATE
GRADUATE MEDICAL EDUCATION PROGRAMS.
Section 340E of the Public Health Service Act (42 U.S.C. 256e) is
amended--
(1) in subsection (a), by striking ``2023'' and inserting
``2028'';
(2) in subsection (b)(3)(D), by inserting ``and the end of
fiscal year 2028,'' after ``fiscal year 2022,'';
(3) in subsection (e), by adding at the end the following
new paragraph:
``(4) Prohibition on payments to hospitals furnishing
specified procedures and drugs to minors.--
``(A) In general.--Notwithstanding any other
provision of this section, no payment may be made under
this section to a children's hospital for a fiscal year
(beginning with fiscal year 2024) if, at any point
during the preceding fiscal year, such hospital
furnished specified procedures and drugs (as defined in
subsection (g)) to an individual under 18 years of age.
``(B) Special rule for fiscal year 2024.--In
applying subparagraph (A) with respect to payments
described in such subparagraph for fiscal year 2024--
``(i) the reference to `for a fiscal year'
shall be treated as a reference to `for any
portion of fiscal year 2024 occurring after
December 31, 2023'; and
``(ii) the reference to `the preceding
fiscal year' shall be treated as a reference to
`the period beginning on September 1, 2023, and
ending on December 31, 2023'.
``(C) Rule of construction.--Nothing in this
paragraph shall be construed as prohibiting payments
for a fiscal year (or, in the case of payments for
fiscal year 2024, during the portion of such fiscal
year described in subparagraph (B)(i)) to a hospital
that, during the preceding fiscal year (or, in the case
of payments for fiscal year 2024, during the period
described in subparagraph (B)(ii)), furnished mental or
behavioral health services to individuals under 18
years of age for the treatment of gender dysphoria not
consisting of specified procedures and drugs.'';
(4) in subsection (f)--
(A) in paragraph (1)(A)--
(i) in clause (v), by striking ``and'' at
the end;
(ii) in clause (vi), by striking the period
at the end and inserting ``; and''; and
(iii) by adding at the end the following:
``(vii) for each of fiscal years 2024
through 2028, $124,000,000.''; and
(B) in paragraph (2)--
(i) in subparagraph (E), by striking
``and'' at the end;
(ii) in subparagraph (F), by striking the
period at the end and inserting ``; and''; and
(iii) by adding at the end the following:
``(G) for each of fiscal years 2024 through 2028,
$261,000,000.''; and
(5) in subsection (g), by adding at the end the following
new paragraph:
``(4) Specified procedures and drugs.--
``(A) In general.--Except as provided in
subparagraph (B), the term `specified procedures and
drugs' means, with respect to an individual, any of the
following:
``(i) Performing any surgery for the
purpose of changing the body of such individual
to correspond to a sex that differs from their
biological sex, including--
``(I) castration;
``(II) orchiectomy;
``(III) scrotoplasty;
``(IV) vasectomy;
``(V) hysterectomy;
``(VI) oophorectomy;
``(VII) ovariectomy;
``(VIII) metoidioplasty;
``(IX) penectomy;
``(X) phalloplasty;
``(XI) vaginoplasty;
``(XII) vaginectomy;
``(XIII) vulvoplasty;
``(XIV) reduction
thyrochondroplasty;
``(XV) chondrolaryngoplasty; and
``(XVI) mastectomy.
``(ii) Any plastic surgery that feminizes
or masculinizes the facial features for the
purposes described in clause (i).
``(iii) Any placement of chest implants to
create feminine breasts for the purposes
described in clause (i).
``(iv) Any placement of fat or artificial
implants in the gluteal region for the purposes
described in clause (i).
``(v) Administering, supplying,
prescribing, dispensing, distributing, or
otherwise conveying to an individual
medications for the purposes described in
clause (i), including--
``(I) gonadotropin-releasing
hormone (GnRH) analogues or other
puberty-blocking drugs to stop or delay
normal puberty;
``(II) testosterone or other
androgens to biological females at
doses that are supraphysiologic to the
female sex; and
``(III) estrogen to biological
males at doses that are
supraphysiologic to the male sex.
``(B) Exception.--Subparagraph (A) shall not apply
to the following individuals:
``(i) An individual with both ovarian and
testicular tissue.
``(ii) An individual with respect to whom a
physician has determined through genetic or
biochemical testing that the individual does
not have normal sex chromosome structure, sex
steroid hormone production, or sex steroid
hormone action.
``(iii) An individual experiencing
infection, disease, injury, or disorder caused
or exacerbated by previous medical procedures
as defined in subsection (g)(4)(A).
``(iv) An individual suffering from a
physical disorder, physical injury, or physical
illness that would, as certified by a
physician, place the individual in imminent
danger of death or impairment of a major bodily
function unless the procedure is performed.
``(C) Biological sex.--For purposes of subparagraph
(A), the term `biological sex' means the indication of
male or female sex by reproductive potential or
capacity, sex chromosomes, naturally occurring sex
hormones, gonads, or internal or external genitalia
present at birth.''.
Union Calendar No. 629
118th CONGRESS
2d Session
H. R. 3887
[Report No. 118-758]
_______________________________________________________________________
A BILL
To amend title III of the Public Health Service Act to reauthorize the
program of payments to children's hospitals that operate graduate
medical education programs, and for other purposes.
_______________________________________________________________________
November 20, 2024
Reported with an amendment, committed to the Committee of the Whole
House on the State of the Union, and ordered to be printed